Annual FCF
-$14.30 M
-$2.22 M-18.39%
March 31, 2024
Summary
- As of February 20, 2025, PRTG annual free cash flow is -$14.30 million, with the most recent change of -$2.22 million (-18.39%) on March 31, 2024.
- During the last 3 years, PRTG annual FCF has fallen by -$10.01 million (-233.73%).
- PRTG annual FCF is now -9632.47% below its all-time high of -$146.90 thousand, reached on March 31, 2003.
Performance
PRTG Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$1.56 M
+$126.00 K+7.47%
September 30, 2024
Summary
- As of February 20, 2025, PRTG quarterly free cash flow is -$1.56 million, with the most recent change of +$126.00 thousand (+7.47%) on September 30, 2024.
- Over the past year, PRTG quarterly FCF has stayed the same.
- PRTG quarterly FCF is now -150.06% below its all-time high of $3.12 million, reached on March 31, 2017.
Performance
PRTG Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$9.80 M
+$2.73 M+21.80%
September 30, 2024
Summary
- As of February 20, 2025, PRTG TTM free cash flow is -$9.80 million, with the most recent change of +$2.73 million (+21.80%) on September 30, 2024.
- Over the past year, PRTG TTM FCF has stayed the same.
- PRTG TTM FCF is now -434.31% below its all-time high of $2.93 million, reached on June 30, 2013.
Performance
PRTG TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
PRTG Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.4% | 0.0% | 0.0% |
| 3 y3 years | -233.7% | +30.7% | -44.9% |
| 5 y5 years | -1566.3% | -25.5% | -132.8% |
PRTG Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -233.7% | at low | at high | +66.7% | -80.4% | +38.2% |
| 5 y | 5-year | -1566.3% | at low | -140.0% | +66.7% | -201.1% | +38.2% |
| alltime | all time | -9632.5% | at low | -150.1% | +68.4% | -434.3% | +38.2% |
Portage Biotech Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.56 M(-7.5%) | -$9.80 M(-21.8%) |
| Jun 2024 | - | -$1.69 M(-46.0%) | -$12.53 M(-12.4%) |
| Mar 2024 | -$14.30 M(+18.4%) | -$3.12 M(-9.0%) | -$14.30 M(-9.8%) |
| Dec 2023 | - | -$3.43 M(-20.1%) | -$15.86 M(+4.8%) |
| Sep 2023 | - | -$4.29 M(+24.3%) | -$15.13 M(+13.3%) |
| Jun 2023 | - | -$3.45 M(-26.2%) | -$13.35 M(+10.6%) |
| Mar 2023 | -$12.08 M(+78.5%) | -$4.68 M(+73.1%) | -$12.08 M(+25.2%) |
| Dec 2022 | - | -$2.70 M(+7.5%) | -$9.65 M(+12.2%) |
| Sep 2022 | - | -$2.52 M(+15.6%) | -$8.60 M(+16.8%) |
| Jun 2022 | - | -$2.18 M(-3.3%) | -$7.36 M(+8.8%) |
| Mar 2022 | -$6.76 M(+57.9%) | -$2.25 M(+35.8%) | -$6.76 M(+24.6%) |
| Dec 2021 | - | -$1.66 M(+30.0%) | -$5.43 M(+18.9%) |
| Sep 2021 | - | -$1.27 M(-19.3%) | -$4.57 M(-11.8%) |
| Jun 2021 | - | -$1.58 M(+72.3%) | -$5.18 M(+20.8%) |
| Mar 2021 | -$4.28 M(+15.3%) | -$917.00 K(+15.5%) | -$4.28 M(+1.8%) |
| Dec 2020 | - | -$794.00 K(-57.9%) | -$4.21 M(+3.5%) |
| Sep 2020 | - | -$1.89 M(+174.0%) | -$4.07 M(+18.8%) |
| Jun 2020 | - | -$688.00 K(-18.3%) | -$3.42 M(-7.8%) |
| Mar 2020 | -$3.71 M(+332.9%) | -$842.00 K(+29.5%) | -$3.71 M(+14.1%) |
| Dec 2019 | - | -$650.00 K(-47.7%) | -$3.25 M(+20.2%) |
| Sep 2019 | - | -$1.24 M(+27.0%) | -$2.71 M(+63.9%) |
| Jun 2019 | - | -$979.00 K(+156.3%) | -$1.65 M(+92.5%) |
| Mar 2019 | -$858.00 K(-20.0%) | -$382.00 K(+267.3%) | -$858.00 K(+24.7%) |
| Dec 2018 | - | -$104.00 K(-44.4%) | -$688.00 K(-27.3%) |
| Sep 2018 | - | -$187.00 K(+1.1%) | -$947.00 K(-6.3%) |
| Jun 2018 | - | -$185.00 K(-12.7%) | -$1.01 M(-5.8%) |
| Mar 2018 | -$1.07 M(-18.8%) | -$212.00 K(-41.6%) | -$1.07 M(-147.6%) |
| Dec 2017 | - | -$363.00 K(+44.6%) | $2.25 M(-6.1%) |
| Sep 2017 | - | -$251.00 K(+1.6%) | $2.40 M(-5.8%) |
| Jun 2017 | - | -$247.00 K(-107.9%) | $2.55 M(-293.0%) |
| Mar 2017 | -$1.32 M(-80.7%) | $3.12 M(-1542.6%) | -$1.32 M(-76.8%) |
| Dec 2016 | - | -$216.00 K(+107.5%) | -$5.69 M(-17.0%) |
| Sep 2016 | - | -$104.10 K(-97.5%) | -$6.85 M(-32.0%) |
| Jun 2016 | - | -$4.12 M(+229.4%) | -$10.07 M(+47.2%) |
| Mar 2016 | -$6.84 M(+161.6%) | -$1.25 M(-9.5%) | -$6.84 M(+3.7%) |
| Dec 2015 | - | -$1.38 M(-58.4%) | -$6.60 M(+16.6%) |
| Sep 2015 | - | -$3.32 M(+275.1%) | -$5.66 M(+81.4%) |
| Jun 2015 | - | -$885.90 K(-12.1%) | -$3.12 M(+19.3%) |
| Mar 2015 | -$2.61 M(+35.1%) | -$1.01 M(+129.4%) | -$2.61 M(-6.2%) |
| Dec 2014 | - | -$439.20 K(-44.0%) | -$2.79 M(+8.4%) |
| Sep 2014 | - | -$784.60 K(+105.2%) | -$2.57 M(+22.5%) |
| Jun 2014 | - | -$382.30 K(-67.6%) | -$2.10 M(+8.4%) |
| Mar 2014 | -$1.94 M(+8.0%) | -$1.18 M(+429.3%) | -$1.94 M(-348.2%) |
| Dec 2013 | - | -$223.00 K(-28.6%) | $779.70 K(+16.6%) |
| Sep 2013 | - | -$312.40 K(+42.3%) | $668.60 K(-77.2%) |
| Jun 2013 | - | -$219.60 K(-114.3%) | $2.93 M(-263.5%) |
| Mar 2013 | -$1.79 M | $1.53 M(-559.4%) | -$1.79 M(-49.8%) |
| Dec 2012 | - | -$334.10 K(-117.1%) | -$3.57 M(+1.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | $1.95 M(-139.4%) | -$3.52 M(-39.1%) |
| Jun 2012 | - | -$4.94 M(+1905.2%) | -$5.77 M(+330.9%) |
| Mar 2012 | -$1.34 M(-49.0%) | -$246.50 K(-10.7%) | -$1.34 M(+35.5%) |
| Dec 2011 | - | -$275.90 K(-10.5%) | -$989.00 K(-16.0%) |
| Sep 2011 | - | -$308.20 K(-39.5%) | -$1.18 M(+11.8%) |
| Jun 2011 | - | -$509.40 K(-587.5%) | -$1.05 M(-59.9%) |
| Mar 2011 | -$2.63 M(-47.0%) | $104.50 K(-122.5%) | -$2.63 M(-31.3%) |
| Dec 2010 | - | -$463.70 K(+152.1%) | -$3.82 M(-43.9%) |
| Sep 2010 | - | -$183.90 K(-91.2%) | -$6.82 M(-1.9%) |
| Jun 2010 | - | -$2.08 M(+90.7%) | -$6.95 M(+40.1%) |
| Mar 2010 | -$4.96 M(+1601.8%) | -$1.09 M(-68.4%) | -$4.96 M(+25.7%) |
| Dec 2009 | - | -$3.46 M(+1006.0%) | -$3.95 M(+696.4%) |
| Sep 2009 | - | -$312.70 K(+222.7%) | -$495.50 K(+74.4%) |
| Jun 2009 | - | -$96.90 K(+24.2%) | -$284.10 K(-2.5%) |
| Mar 2009 | -$291.50 K(-38.7%) | -$78.00 K(+887.3%) | -$291.50 K(+6.3%) |
| Dec 2008 | - | -$7900.00(-92.2%) | -$274.20 K(-24.4%) |
| Sep 2008 | - | -$101.30 K(-2.9%) | -$362.60 K(-10.9%) |
| Jun 2008 | - | -$104.30 K(+71.8%) | -$406.80 K(-14.5%) |
| Mar 2008 | -$475.70 K(+2.9%) | -$60.70 K(-37.0%) | -$475.70 K(-23.4%) |
| Dec 2007 | - | -$96.30 K(-33.8%) | -$621.10 K(+28.8%) |
| Sep 2007 | - | -$145.50 K(-16.0%) | -$482.40 K(+47.2%) |
| Jun 2007 | - | -$173.20 K(-16.0%) | -$327.70 K(-29.1%) |
| Mar 2007 | -$462.40 K(-87.8%) | -$206.10 K(-586.1%) | -$462.50 K(+578.2%) |
| Dec 2006 | - | $42.40 K(+360.9%) | -$68.20 K(+180.7%) |
| Sep 2006 | - | $9200.00(-103.0%) | -$24.30 K(-99.3%) |
| Jun 2006 | - | -$308.00 K(-263.7%) | -$3.44 M(-9.3%) |
| Mar 2006 | -$3.79 M(+1077.8%) | $188.20 K(+118.1%) | -$3.79 M(-4.7%) |
| Dec 2005 | - | $86.30 K(-102.5%) | -$3.97 M(-34.6%) |
| Sep 2005 | - | -$3.40 M(+416.7%) | -$6.08 M(+113.6%) |
| Jun 2005 | - | -$658.50 K(-67.3%) | -$2.84 M(+2.1%) |
| Dec 2004 | - | -$2.01 M(+1074.5%) | -$2.79 M(-634.1%) |
| Sep 2004 | - | -$171.50 K(-50.7%) | $521.80 K(-179.8%) |
| Jun 2004 | - | -$348.20 K(+37.6%) | -$654.20 K(+103.5%) |
| Mar 2004 | -$321.50 K(+118.9%) | -$253.00 K(-119.5%) | -$321.50 K(+344.1%) |
| Dec 2003 | - | $1.29 M(-196.1%) | -$72.40 K(-94.9%) |
| Sep 2003 | - | -$1.35 M(+8593.5%) | -$1.42 M(+1130.6%) |
| Jun 2003 | - | -$15.50 K(+297.4%) | -$115.20 K(-21.5%) |
| Mar 2003 | -$146.90 K(-6.4%) | -$3900.00(-92.3%) | -$146.80 K(-37.7%) |
| Dec 2002 | - | -$50.80 K(+12.9%) | -$235.70 K(-0.8%) |
| Sep 2002 | - | -$45.00 K(-4.5%) | -$237.60 K(+25.4%) |
| Jun 2002 | - | -$47.10 K(-49.2%) | -$189.50 K(+20.7%) |
| Mar 2002 | -$157.00 K(-56.2%) | -$92.80 K(+76.1%) | -$157.00 K(+144.5%) |
| Dec 2001 | - | -$52.70 K(-1800.0%) | -$64.20 K(+458.3%) |
| Sep 2001 | - | $3100.00(-121.2%) | -$11.50 K(-21.2%) |
| Jun 2001 | - | -$14.60 K | -$14.60 K |
| Mar 2001 | -$358.30 K(-17.8%) | - | - |
| Mar 2000 | -$435.70 K(+21.4%) | - | - |
| Mar 1999 | -$359.00 K(-15.3%) | - | - |
| Mar 1998 | -$423.80 K | - | - |
FAQ
- What is Portage Biotech annual free cash flow?
- What is the all time high annual FCF for Portage Biotech?
- What is Portage Biotech annual FCF year-on-year change?
- What is Portage Biotech quarterly free cash flow?
- What is the all time high quarterly FCF for Portage Biotech?
- What is Portage Biotech quarterly FCF year-on-year change?
- What is Portage Biotech TTM free cash flow?
- What is the all time high TTM FCF for Portage Biotech?
- What is Portage Biotech TTM FCF year-on-year change?
What is Portage Biotech annual free cash flow?
The current annual FCF of PRTG is -$14.30 M
What is the all time high annual FCF for Portage Biotech?
Portage Biotech all-time high annual free cash flow is -$146.90 K
What is Portage Biotech annual FCF year-on-year change?
Over the past year, PRTG annual free cash flow has changed by -$2.22 M (-18.39%)
What is Portage Biotech quarterly free cash flow?
The current quarterly FCF of PRTG is -$1.56 M
What is the all time high quarterly FCF for Portage Biotech?
Portage Biotech all-time high quarterly free cash flow is $3.12 M
What is Portage Biotech quarterly FCF year-on-year change?
Over the past year, PRTG quarterly free cash flow has changed by $0.00 (0.00%)
What is Portage Biotech TTM free cash flow?
The current TTM FCF of PRTG is -$9.80 M
What is the all time high TTM FCF for Portage Biotech?
Portage Biotech all-time high TTM free cash flow is $2.93 M
What is Portage Biotech TTM FCF year-on-year change?
Over the past year, PRTG TTM free cash flow has changed by $0.00 (0.00%)